Lonza IPF airway cells

Tuesday, 21 February, 2017 | Supplied by: Capsugel Australia Pty Ltd

Lonza now offers cryopreserved lung fibroblasts isolated from donors diagnosed with idiopathic pulmonary fibrosis (IPF) for use in research into this potentially fatal condition. Normal lung fibroblasts and small airway epithelial cells — from both smokers and non-smokers — are also available, offering a complete solution to facilitate IPF and other airway research.

Research into IPF is a rapidly growing field; however, a considerable amount of research is still needed if a cure is to be found, as the pathways of disease progression are not yet understood. Furthermore, IPF tissue has until now been difficult for researchers to source.

By providing IPF cells, Lonza makes it convenient for users to quickly progress with their research. The company’s ability to provide primary cells, coupled with detailed donor information, enables researchers to relate donor characteristics to disease progression.

The IPF cells are available together with normal lung fibroblast cells and culture media, providing a complete cell culture solution for IPF research. In addition, the company has the capability to provide custom isolations where required.

Online: www.capsugel.com
Phone: 1300 657508
Related Products

Enzo Life Sciences SUPERKILLERTRAIL protein (soluble) (human), (recombinant)

Enzo Life Sciences' SUPERKILLERTRAIL (soluble) (human), (recombinant) is an enhanced ligand...

Diaclone ELISpot Kits

Diaclone's ELISpot Kits are highly specific immunoassays for the analysis of the production...

Bio-Rad Laboratories Bio-Plex Pro Human SARS-CoV-2 Variant Neutralization Antibody Assays

The assays allow scientists to measure neutralising antibodies quickly and efficiently against...

  • All content Copyright © 2022 Westwick-Farrow Pty Ltd